Multicomponent Language Treatment for Primary Progressive Aphasia
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests an online program designed to assist individuals with primary progressive aphasia (PPA), a type of dementia affecting speech and language. The goal is to determine if online speech-language therapy can enhance communication skills and benefit both patients and their care partners. The trial will evaluate three therapy methods—Multicomponent Communication Partner Training (Multi-CPT), Multicomponent Lexical Retrieval Training (Multi-LRT), and Multicomponent Video Implemented Script Training in Aphasia (Multi-VISTA)—to identify the most effective approach. Individuals diagnosed with PPA who have a partner available to join the sessions may be suitable candidates. Participants will engage in online therapy, complete tasks and surveys, and have virtual check-ins with the research team. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could improve communication strategies for PPA.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It might be best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that the treatments in this trial are generally safe for participants. Here's a simple breakdown:
1. **Multicomponent Lexical Retrieval Training (Multi-LRT)**: Similar therapies, such as those using smartphone apps, have improved language skills over six months without major safety issues. This suggests that Multi-LRT is likely safe and well-tolerated.
2. **Multicomponent Video Implemented Script Training in Aphasia (Multi-VISTA)**: Research on a modified version of this therapy has shown it to be practical and acceptable. Participants found it manageable and effective, with no significant side effects reported.
3. **Multicomponent Communication Partner Training (Multi-CPT)**: This method has been studied in people with progressive aphasia, and results show it is practical and can help improve understanding of aphasia. Studies reported no major safety concerns.
Overall, these treatments have been tested for their ability to aid communication in people with primary progressive aphasia, and they appear safe and tolerable based on existing research.12345Why are researchers excited about this trial?
Researchers are excited about the multicomponent treatments for Primary Progressive Aphasia (PPA) because they take a comprehensive approach to tackle language deterioration. Unlike standard therapies, which often focus on a single aspect of language, these treatments integrate multiple strategies. Multi-CPT emphasizes training communication partners, enhancing the patient's daily interactions. Multi-LRT targets specific word retrieval processes, aiming to improve vocabulary access. Meanwhile, Multi-VISTA uses video-based script training, offering a practical, context-rich method to reinforce language skills. Together, these treatments provide a more holistic approach to managing PPA, potentially leading to more significant improvements in communication.
What evidence suggests that this trial's treatments could be effective for primary progressive aphasia?
This trial will compare three different treatments for primary progressive aphasia (PPA). Studies have shown that Multicomponent Lexical Retrieval Training (Multi-LRT), one of the treatments in this trial, helps people with PPA find words more easily. Participants in these studies demonstrated better naming skills and maintained these improvements over time. Another treatment option in this trial, Multicomponent Video Implemented Script Training in Aphasia (Multi-VISTA), enhances communication in people with PPA by using video scripts, which are structured speaking exercises. This method is both practical and effective, leading to better communication in practiced situations. Lastly, Multicomponent Communication Partner Training (Multi-CPT) teaches caregivers and partners how to better communicate with people who have PPA. This approach has improved understanding and communication between patients and their partners. Together, these treatments offer promising ways to help people with PPA improve their communication skills.13567
Who Is on the Research Team?
Maya L Henry, PhD
Principal Investigator
University of Texas - Austin
Are You a Good Fit for This Trial?
This trial is for adults diagnosed with Primary Progressive Aphasia (PPA) who can still score at least 10 on the Mini-Mental State Examination. They must have a partner to attend sessions with them. It's not suitable for those with major visual/hearing issues, other cognitive/behavioral/motor impairments, or additional neurological/psychiatric conditions affecting language skills.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a multicomponent intervention incorporating restitutive, compensatory, and care partner-focused treatments
Follow-up
Participants are monitored for changes in script production accuracy, spoken naming, and other communication measures
What Are the Treatments Tested in This Trial?
Interventions
- Multicomponent Communication Partner Training (Multi-CPT)
- Multicomponent Lexical Retrieval Training (Multi-LRT)
- Multicomponent Video Implemented Script Training in Aphasia (Multi-VISTA)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Texas at Austin
Lead Sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator